# Post Market Clinical Follow-Up of Acetabular Titan-Augment Structan®

> **NCT02019433** · — · TERMINATED · sponsor: **Aesculap AG** · enrollment: 5 (actual)

## Conditions studied

- Total Hip Arthroplasty Revision

## Interventions

- **DEVICE:** Structan®

## Key facts

- **NCT ID:** NCT02019433
- **Lead sponsor:** Aesculap AG
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** TERMINATED
- **Start date:** 2012-07
- **Primary completion:** 2014-09
- **Final completion:** 2014-12
- **Target enrollment:** 5 (ACTUAL)
- **Last updated:** 2017-01-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02019433

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02019433, "Post Market Clinical Follow-Up of Acetabular Titan-Augment Structan®". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT02019433. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*